Evidence map›Paper›PMID 35585092›Full record

ArticleScientific reports2022

Enhanced anticancer potency with reduced nephrotoxicity of newly synthesized platin-based complexes compared with cisplatin.

Roya Salehi, Selda Abyar, Fatemeh Ramazani, Ali Akbar Khandar, Seyed Abolfazl Hosseini-Yazdi, Jonathan M White, Mahdi Edalati, Houman Kahroba, Mehdi Talebi

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.4field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Palladium and platinum complexes based on pyridine bases induced anticancer effectiveness via apoptosis protein signaling in cancer cells.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2024
    Article
  5. Desulfurization of thiosemicarbazones: the role of metal ions and biological implications.Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2024
    Review
  6. Exploring the Biological Properties of Zn(II)International journal of molecular sciences · 2023
    Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 4 countries.

Roya SalehiDrug Applied Research Center and Department of Medical Nanotechnology, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, 5165665811, Tabriz, Iran. salehiro@tbzmed.ac.ir.
Selda AbyarDepartment of Inorganic Chemistry, Faculty of Chemistry, University of Tabriz, 5166614766, Tabriz, Iran.
Fatemeh RamazaniDepartment of Molecular Medicine, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.
Ali Akbar KhandarDepartment of Inorganic Chemistry, Faculty of Chemistry, University of Tabriz, 5166614766, Tabriz, Iran. akhandar@yahoo.com.
Seyed Abolfazl Hosseini-YazdiDepartment of Inorganic Chemistry, Faculty of Chemistry, University of Tabriz, 5166614766, Tabriz, Iran.
Jonathan M WhiteSchool of Chemistry and BIO-21 Institute, University of Melbourne, Parkville, Vic., 3010, Australia.
Mahdi EdalatiDepartment of Laboratory Sciences, Paramedical Faculty, Tabriz University of Medical Sciences, Tabriz, Iran.
Houman KahrobaDepartment of Toxicogenomics, GROW School for Oncology and Department Biology, Maastricht University, Maastricht, The Netherlands.
Mehdi TalebiDepartment of Applied Cell Science, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, 5154853431, Iran.
Tabriz University of Medical Sciences · IRUniversity of Tabriz · IRHasselt University · BEUniversity of Melbourne · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As a platinum-containing anticancer drug, cisplatin is the keystone for treating many malignancies. Nephrotoxicity is the main dose-limiting toxicity, and several hydration therapies and supplementary strategies are utilized to reduce cisplatin-induced kidney damage, so the discovery and development of effective and safe antitumor drugs are still on the path of human health. Herein, a new four-coordinated Pt complex [Pt(TSC)Cl] using N(4)-phenyl-2-formylpyridine thiosemicarbazone (HTSC) was synthesized and characterized by single-crystal X-ray diffraction,

Indexed as

Antineoplastic AgentsCisplatinApoptosisCaco-2 CellsCell Line, TumorHEK293 CellsHumansSpectroscopy, Fourier Transform InfraredAntineoplastic AgentsCisplatin

Identifiers

PMID35585092
PMCPMC9117324
OpenAlexW4280578462

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.